The Beam Alliance is an association of about 50 European SMEs involved in the development of antibiotics, antimicrobials and alternative approaches. Its objective is to give a voice to the SMEs, pivotal actors of the value chain of Antibiotics R&D.
Drive-AB is a IMI project part of the New Drugs For Bad Bugs (ND4BB) umbrella whose objectives is to suggest new economic models tailored to rejuvenate the antibiotics R&D pipeline. It ambitioned to gather all relevant stakeholders but the SMEs had been overlooked. With the addition of BEAM all the relevant actors can join the study.